84 related articles for article (PubMed ID: 1968342)
1. Inhibition of HIV-1 infectivity with curdlan sulfate in vitro.
Kaneko Y; Yoshida O; Nakagawa R; Yoshida T; Date M; Ogihara S; Shioya S; Matsuzawa Y; Nagashima N; Irie Y
Biochem Pharmacol; 1990 Feb; 39(4):793-7. PubMed ID: 1968342
[No Abstract] [Full Text] [Related]
2. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro.
Jagodzinski PP; Wiaderkiewicz R; Kurzawski G; Kloczewiak M; Nakashima H; Hyjek E; Yamamoto N; Uryu T; Kaneko Y; Posner MR
Virology; 1994 Aug; 202(2):735-45. PubMed ID: 7913276
[TBL] [Abstract][Full Text] [Related]
4. Curdlan sulfate and HIV-1: II. In vitro long-term treatment of HIV-1 infection with curdlan sulfate.
Aoki T; Kaneko Y; Nguyen T; Stefanski MS; Ting RC; Manak MM
AIDS Res Hum Retroviruses; 1992 May; 8(5):605-12. PubMed ID: 1515213
[TBL] [Abstract][Full Text] [Related]
5. Role of curdlan sulfate in the production of beta-chemokines and interleukin-16.
Naito T; Takeda-Hirokawa N; Kaneko H; Sekigawa I; Matsumoto T; Hashimoto H; Kaneko Y
Med Microbiol Immunol; 1998 Jun; 187(1):43-8. PubMed ID: 9749981
[TBL] [Abstract][Full Text] [Related]
6. Role of the V2, V3, and CD4-binding domains of GP120 in curdlan sulfate neutralization sensitivity of HIV-1 during infection of T lymphocytes.
Jagodzinski PP; Wustner J; Kmieciak D; Wasik TJ; Fertala A; Sieron AL; Takahashi M; Tsuji T; Mimura T; Fung MS; Gorny MK; Kloczewiak M; Kaneko Y; Kozbor D
Virology; 1996 Dec; 226(2):217-27. PubMed ID: 8955041
[TBL] [Abstract][Full Text] [Related]
7. [Sulfated curdlan and sulfated alkyl oligosaccharide as anti-viral agent].
Uryu T
Nihon Rinsho; 1993 Sep; 51 Suppl():164-8. PubMed ID: 8271380
[No Abstract] [Full Text] [Related]
8. Synthesis of curdlan sulfates having inhibitory effects in vitro against AIDS viruses HIV-1 and HIV-2.
Yoshida T; Yasuda Y; Mimura T; Kaneko Y; Nakashima H; Yamamoto N; Uryu T
Carbohydr Res; 1995 Oct; 276(2):425-36. PubMed ID: 8542610
[No Abstract] [Full Text] [Related]
9. Effect of curdlan sulfate on the production of beta-chemokines and cytokines.
Takeda-Hirokawa N; Neoh LP; Akimoto H; Kaneko H; Hishikawa T; Hashimoto H; Sekigawa I; Hirose S; Yamanoto N; Kaneko Y
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):723-5. PubMed ID: 9643371
[No Abstract] [Full Text] [Related]
10. Curdlan sulfate induces the downmodulation of chemokine receptors leading to suppression of HIV infection.
Naito T; Okada M; Ogasawara H; Kaneko H; Hishikawa T; Matsumoto T; Sekigawa I; Hashimoto H; Kaneko Y
J Acquir Immune Defic Syndr; 2001 Apr; 26(5):512-3. PubMed ID: 11391175
[No Abstract] [Full Text] [Related]
11. Further clinical studies of curdlan sulfate (CRDS)--an anti-HIV agent.
Gordon M; Guralnik M; Kaneko Y; Mimura T; Goodgame J; Lang W
J Med; 1995; 26(3-4):97-131. PubMed ID: 8558101
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of curdlan sulfate--an HIV inhibitor. Tolerance, pharmacokinetics and effects on coagulation and on CD4 lymphocytes.
Gordon M; Guralnik M; Kaneko Y; Mimura T; Baker M; Lang W
J Med; 1994; 25(3-4):163-80. PubMed ID: 7996061
[TBL] [Abstract][Full Text] [Related]
13. Sulfated alkyl oligosaccharides with potent inhibitory effects on human immunodeficiency virus infection.
Uryu T; Ikushima N; Katsuraya K; Shoji T; Takahashi N; Yoshida T; Kanno K; Murakami T; Nakashima H; Yamamoto N
Biochem Pharmacol; 1992 Jun; 43(11):2385-92. PubMed ID: 1351727
[TBL] [Abstract][Full Text] [Related]
14. Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity.
Gordon M; Deeks S; De Marzo C; Goodgame J; Guralnik M; Lang W; Mimura T; Pearce D; Kaneko Y
J Med; 1997; 28(1-2):108-28. PubMed ID: 9249617
[TBL] [Abstract][Full Text] [Related]
15. Effects of curdlan and gellan gum on the surface structure of intestinal mucosa in rats.
Tetsuguchi M; Nomura S; Katayama M; Sugawa-Katayama Y
J Nutr Sci Vitaminol (Tokyo); 1997 Oct; 43(5):515-27. PubMed ID: 9505237
[TBL] [Abstract][Full Text] [Related]
16. Babesia bigemina: in vitro and in vivo effects of curdlan sulfate on growth of parasites.
Igarashi I; Njonge FK; Kaneko Y; Nakamura Y
Exp Parasitol; 1998 Nov; 90(3):290-3. PubMed ID: 9806875
[No Abstract] [Full Text] [Related]
17. Acute pulmonary toxicity of inhaled beta-1,3-glucan and endotoxin.
Fogelmark B; Goto H; Yuasa K; Marchat B; Rylander R
Agents Actions; 1992 Jan; 35(1-2):50-6. PubMed ID: 1509978
[TBL] [Abstract][Full Text] [Related]
18. Effects of particulate beta-1,3 glucan on human, rat, and guinea pig complement activity.
Glovsky MM; Cortes-Haendchen L; Ghekiere L; Alenty A; Williams DL; Di Luzio R
J Reticuloendothel Soc; 1983 May; 33(5):401-13. PubMed ID: 6601707
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6.
Demleitner S; Kraus J; Franz G
Carbohydr Res; 1992 Mar; 226(2):239-46. PubMed ID: 1617687
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary inflammation induced by repeated inhalations of beta(1,3)-D-glucan and endotoxin.
Fogelmark B; Sjöstrand M; Rylander R
Int J Exp Pathol; 1994 Apr; 75(2):85-90. PubMed ID: 8199009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
